Filing Flows

Filing Flows › Xenon Pharmaceuticals (XENE) › Next earnings date

Xenon Pharmaceuticals (XENE) earnings on Nov 9, 2026: what to expect

Xenon Pharmaceuticals (XENE) is expected to report earnings on Nov 9, 2026, tomorrow, for the quarter ending Sep 30, 2026. Analysts expect EPS of −$1.14 (−$1.29 to −$0.94, 11 estimates), against −$1.15 a year ago. It beat the EPS estimate in 75% of the quarters on record; Filing Flows' model gives it a 75% chance of beating next time.

Report dateNov 9, 2026
Days to go1
EPS estimate−$1.14
Beat rate75%

The last report

Xenon Pharmaceuticals reported revenue of $7.5M for the first quarter 2025, net loss $65.0M. How it makes money → · Every quarter →

Xenon Pharmaceuticals: EPS against the estimate, last 4 reportsXenon Pharmaceuticals: EPS against the estimate, last 4 reportsEstimateReported−$1.16−$1.15Nov 25−$1.21−$1.31Feb 26−$1.20−$1.17May 26−$1.16−$1.11Aug 26
Latest (Aug 26): Estimate −$1.16, Reported −$1.11.
XENE: the stock's move on each reportXENE: the stock's move on each reportAug 6, 2026-1.5%May 7, 2026-3.7%Feb 26, 2026-3.0%Nov 3, 2025-6.8%

Xenon Pharmaceuticals' latest quarter

Xenon Pharmaceuticals, Q1 2025: revenue $7.5M, operating margin -969.8%, net loss $65.0M, operating cash flow −$61.7M. The chart follows the revenue to costs, profit and cash.

Questions

When does XENE report earnings?

Xenon Pharmaceuticals is expected to report on Nov 9, 2026.

What are analysts expecting from Xenon Pharmaceuticals?

EPS of −$1.14 for the quarter.

Does Xenon Pharmaceuticals usually beat earnings?

It beat the consensus EPS estimate in 75% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.